(Q73690421)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871282%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Heparin-induced thrombocytopenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871282%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Chong BH

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871282%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871282%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871282%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871282%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871282%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

1471-1478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871282%20AND%20SRC:MED&resulttype=core&format=json

The in vivo release of human platelet factor 4 by heparin

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Further characterization of antibody and antigen in heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Heparin-associated thrombocytopenia: case report and prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Disseminated Intravascular Coagulation During Heparin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Diagnosis, treatment and pathophysiology of autoimmune thrombocytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

A 14-year study of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00270.X

10.1046/J.1538-7836.2003.00270.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12871282%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference